Annual Operating Expenses
$2.16 M
+$1.93 M+853.45%
01 December 2023
Summary:
Lipella Pharmaceuticals Common Stock annual total operating expenses is currently $2.16 million, with the most recent change of +$1.93 million (+853.45%) on 01 December 2023. During the last 3 years, it has risen by +$2.11 million (+4962.68%). LIPO annual operating expenses is now at all-time high.LIPO Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$412.70 K
+$122.10 K+42.02%
01 September 2024
Summary:
Lipella Pharmaceuticals Common Stock quarterly total operating expenses is currently $412.70 thousand, with the most recent change of +$122.10 thousand (+42.02%) on 01 September 2024. Over the past year, it has dropped by -$312.30 thousand (-43.08%). LIPO quarterly operating expenses is now -43.08% below its all-time high of $725.00 thousand, reached on 01 December 2023.LIPO Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LIPO Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -43.1% |
| 3 y3 years | +4962.7% | +345.7% |
| 5 y5 years | - | - |
LIPO Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +4962.7% | -43.1% | +972.0% |
| 5 y | 5 years | at high | +4962.7% | -43.1% | +972.0% |
| alltime | all time | at high | +4962.7% | -43.1% | +972.0% |
Lipella Pharmaceuticals Common Stock Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $412.70 K(+42.0%) |
| June 2024 | - | $290.60 K(-22.5%) |
| Mar 2024 | - | $375.00 K(-48.3%) |
| Dec 2023 | $2.16 M(+853.4%) | $725.00 K(+38.5%) |
| Sept 2023 | - | $523.50 K(+1.1%) |
| June 2023 | - | $517.60 K(+32.5%) |
| Mar 2023 | - | $390.70 K(+498.3%) |
| Dec 2022 | $226.20 K | $65.30 K(+5.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $61.70 K(+60.3%) |
| June 2022 | - | $38.50 K(-59.0%) |
| Mar 2022 | - | $93.90 K(+1.4%) |
| Dec 2021 | $718.40 K(+1586.4%) | - |
| Dec 2021 | - | $92.60 K(+102.2%) |
| Sept 2021 | - | $45.80 K(-67.5%) |
| June 2021 | - | $140.90 K(-67.9%) |
| Mar 2021 | - | $439.10 K |
| Dec 2020 | $42.60 K | - |
FAQ
- What is Lipella Pharmaceuticals Common Stock annual total operating expenses?
- What is the all time high annual operating expenses for Lipella Pharmaceuticals Common Stock?
- What is Lipella Pharmaceuticals Common Stock quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Lipella Pharmaceuticals Common Stock?
- What is Lipella Pharmaceuticals Common Stock quarterly operating expenses year-on-year change?
What is Lipella Pharmaceuticals Common Stock annual total operating expenses?
The current annual operating expenses of LIPO is $2.16 M
What is the all time high annual operating expenses for Lipella Pharmaceuticals Common Stock?
Lipella Pharmaceuticals Common Stock all-time high annual total operating expenses is $2.16 M
What is Lipella Pharmaceuticals Common Stock quarterly total operating expenses?
The current quarterly operating expenses of LIPO is $412.70 K
What is the all time high quarterly operating expenses for Lipella Pharmaceuticals Common Stock?
Lipella Pharmaceuticals Common Stock all-time high quarterly total operating expenses is $725.00 K
What is Lipella Pharmaceuticals Common Stock quarterly operating expenses year-on-year change?
Over the past year, LIPO quarterly total operating expenses has changed by -$312.30 K (-43.08%)